Orthokeratology Lens Market Size, Share & COVID-19 Impact Analysis, By Type (Overnight Lens and Daytime Lens), By Age Group (Children and Adults), By Application (Myopia, Astigmatism, and Others), By End-user (Optometrist Offices, Hospitals & Ophthalmology Clinics, and Others), and Regional Forecast, 2022-2029

The orthokeratology lens market size was valued at USD 683.5 million in 2021 and is projected to grow USD 763.9 million in 2022 to USD 2,043.6 million by 2029, exhibiting a CAGR of 15.1% during 2022-2029. Asia Pacific dominated the global market with a share of 52.23% in 2021.

Based on our analysis, the global market exhibited a decline of 10.8% in 2020 as compared to 2019. Orthokeratology lens (OK Lens) is a special gas-permeable lens designed for corneal reshaping suitable for all age groups. These lenses can be worn overnight and allow patients to be free of spectacles and contact lenses during the daytime. These lenses correct refractive errors such as myopia, astigmatism, and hyperopia. Several latest studies show that orthokeratology treatment is one of the effective ways to slow down myopia progression in children. Some healthcare providers in some countries also prescribe these lenses as daytime ortho-K lenses.

The increasing prevalence of refractive errors such as myopia, astigmatism, and hyperopia among the population globally and rising awareness regarding the benefits of these lenses in the treatment are some of the major factors expected to fuel the demand for this lens in the market.

• As per a 2019 article published by the U.S. National Eye Institute, approximately 42% of the U.S. population suffer from myopia.


• Similarly, according to an article published by the Australian National University, the prevalence of myopia in East and Southeast Asia is around 80-90% in young adults.

However, the lack of reimbursement policies for the orthokeratology treatment and the high cost of overall fitting and post-fitting care of orthokeratology lens are some of the factors that might limit the orthokeratology lens market growth during the forecast period.

COVID-19 IMPACT 

Declined Number of Patient Visits and Diagnosis Rate amid the COVID-19 Pandemic Hampered Ortho-K Lens’ Demand 

The COVID-19 pandemic negatively affected market growth during the forecast period. The reduced number of patient visits to optometrist clinics and hospitals for eye check-ups due to lockdown restrictions was one of the primary reasons for the lower demand for these lenses among the population.

Additionally, the number of lens fitting among patients declined during the COVID-19 pandemic due to reduced demand for lenses among the myopia population.

• For instance, a 2021 survey of optometrists published by Contact Lens Spectrum from Mexico reported a 63% decline in the frequency of fitting and refitting lenses, and 58% also noted a decrease in sales of the lenses.

Therefore, limited social interaction and lack of patient access due to the disruption in operations in optometrist offices and ophthalmology clinics were major factors attributable to the decline in the use of lenses among the population.

The major market players also reported a decline in their 2020 revenue due to decreased demand for lenses and sales of the products globally. The market players also faced a slight disruption in operations due to COVID-19 restrictions.

According to the 2020 annual report of the Cooper Companies Inc., the sales from the non-single use sphere and other segments declined to USD 518.8 million in 2020 from USD 581.8 million in 2019. The decline was majorly due to the reduced number of patient visits during COVID-19 and the postponement of ophthalmology services among the healthcare providers.

However, the prevalence of myopia significantly increased after the COVID-19 pandemic, especially in children. Some of the major factors attributable to rise in myopia cases are: increased screen time at home and decreased time spent outdoors. According to the 2021 survey by the Ministry of Education in China, the prevalence of myopia in children in 2020 increased by around 20% compared to the rate in 2019.

The market players also recovered their revenues in 2021 and witnessed growth due to resumed operations and increased demand for lenses globally. For instance, in 2021, the Cooper Companies Inc. generated USD 599.6 million and witnessed a growth rate of around 16% in its non-single-use sphere and other segments. The increase was primarily driven by Biofinity and orthokeratology lenses.

Thus, the growing patient population and the resumption of ophthalmologic practices and services are expected to augment the market growth in the coming years.

LATEST TRENDS 

Request a Free sample to learn more about this report.

Shifting Consumer Preference for Non-Surgical Procedures for Vision Correction to Propel Market Growth

Various vision correction surgeries are available for refractive errors such as myopia, and astigmatism, including LASIK surgeries, Photorefractive Keratectomy (PRK) surgeries, refractive lens exchange, and others.

However, some of the side effects associated with these surgeries, such as dry eye, itching, distorted vision, glare, and halos around lights at night, lead to a reduced number of these procedures among the population.

• For instance, according to a 2020 article, 20-40% of the patients who undergo the surgical procedure face dry eye and itching after the surgery, and about 20% of people who have LASIK have difficulty with contrast and face glare and halos around light at night.

Additionally, limited options available for refractive error correction among children is one of the important factors leading to shifting preference toward orthokeratology lens among the children group. Moreover, eliminating the need to wear spectacles and contact lenses during the daytime is another contributing factor to the rising adoption of these lenses among children.

Furthermore, technological advancements in these lens fitting favor the rising awareness regarding the lens and adoption of these lenses among the population.

• For instance, in September 2021, Scotlens, one of the specialty contact lens manufacturers, collaborated with Avizor to launch a new unboxing experience for ortho-K lenses to increase awareness about the option.

Thus, the increasing number of product approvals and launches by major market players and rising technological advancements and benefits of these lenses are expected to increase the growth opportunities for non-surgical procedures for refractive error correction.

ORTHOKERATOLOGY LENS MARKET GROWTH FACTORS

Growing Prevalence of Refractive Errors Among the Population Along with the Advantages of Orthokeratology Lens to Fuel Market Growth

The global prevalence of refractive errors such as myopia, astigmatism, and hyperopia among the population is significantly rising, especially after the COVID-19 pandemic. The increasing screen time among the population is one of the major factors responsible for the growing prevalence of myopia.

• According to a 2020 article published by BMC Ophthalmology, myopia prevalence in Asia is around 60% and the prevalence in Europe is around 40%. The total number of myopia population is projected to reach around 4.8 billion by 2050.


• According to a 2021 article published by the Lancet Journal, there was an increase of 50-70% internet use during the COVID-19 pandemic. This factor is expected to increase the refractive error prevalence globally.

Several treatment options are available for the patient's refractive error correction such as LASIK surgeries, spectacles, and others. However, these alternative treatments are limited to myopia control and do not slow down the progression of myopia. Several latest studies show orthokeratology treatment can slow down myopia progression in children when started at an early stage.

• According to a 2020 article published by Annals of Eye Science, clinical trials show a reduction in axial eye elongation by around 40-45% in progressive myopic children.

Thus, the increasing benefits of these lenses and the growing prevalence rate of refractive errors and diagnoses among the population are expected to fuel the market.

Increasing R&D Investments in Ortho-K Lens to Propel Market Growth

The increasing demand for orthokeratology lenses among the population owing to their benefits and efficacy is leading the major market players to shift their focus toward these products. The rising efforts of the market players are leading to a higher number of product approvals to cater to the demand for the lens in the market.

• In May 2021, the Cooper Companies Inc. received CE approval from the European Union for Dreamlite OK Lens to slow myopia progression among children and young adults.

Additionally, a growing number of strategic acquisitions and partnerships among the major players is leading to a rising number of product launches to cater to population's demand.

• In January 2022, Johnson & Johnson Vision Care, Inc. launched ACUVUE Abiliti overnight therapeutic lenses to help children with myopia management in Singapore.

Thus, the increasing research and development activities by the major market players and rising technological advancements with a wider application area are expected to drive market growth during the orthokeratology lens market forecast period.

RESTRAINING FACTORS

High Cost Associated with Treatment and Inadequate Reimbursement Policies to Hamper Market Growth 

The cost of orthokeratology varies based on the optometrist, type and level of refractive error, which is a higher level of refractive error may require more than one fitted lens and several other factors. The direct cost associated with orthokeratology includes the lens cost, and fitting cost. The higher price range of this treatment is expected to limit the adoption of these lenses in emerging regions.

• For instance, according to a 2021 article published by CareCredit, the treatment can range from USD 1,200 to USD 2,000 with difficult cases with a higher level of error can even cost up to USD 4,000. Also, the additional costs, including replacement lenses, lens solution, follow-up examination and consultation charges, and others range from USD 300 to 500 per year.

Furthermore, orthokeratology treatment is considered an elective surgery as the treatment is usually not covered completely under reimbursement policies. This factor increases the financial burden on the patient due to higher out-of-pocket expenditure.

• As per a 2020 article published by Eyecare Concepts, the Myopic Clinic, there is no Medicare coverage for complete orthokeratology fitting and usually only covers general eye tests and eye health consultations.

Thus, higher costs associated with these lenses and inadequate reimbursement policies are expected to restrict the adoption of these lenses among the population.

SEGMENTATION

By Type Analysis

Overnight Lens to Grow Owing to Rising Technology Advancements and Increasing Benefits among the Population

On the basis of type, the market is segmented into overnight lens and daytime lens.

The rising advancements in the material used in these lenses are leading to the increasing use of overnight lens among the population.

These lenses are worn at night while sleeping, increasing comfort and eliminating the need to wear eyeglasses or contact lenses during the daytime.

Additionally, the rising efforts of the market players to introduce innovative products are expected to increase the segmental market share during the forecast period. For instance, in May 2021, Euclid Systems Corporation launched Euclid MAX Overnight Ortho-K Lens in the U.S. for children and adult patients with progressive myopia.

By Age Group Analysis

Children Segment to Lead Backed by its Effectiveness to Cure Kids Suffering from Myopia 

On the basis of age group, the market is segmented into children and adults.

The increasing prevalence of myopia, astigmatism, and other refractive errors in children, especially after the COVID-19 pandemic is one of the major factors attributable to the rising adoption of these lenses in this age group. Additionally, the increasing number of clinical studies demonstrating the benefit of orthokeratology lenses in slowing down myopia progression in children at an early stage is anticipated to increase the use of these lenses in this age group.

• According to a 2021 clinical study result published by the U.S. National Institute of Health, there was around 35-50% decline in myopia progression in the children group wearing orthokeratology lenses compared to the group wearing spectacles and contact lenses.

Thus, when coupled with limited options for vision correction treatment in children, these factors are anticipated to propel the segmental growth during the forecast period.

Similarly, the increasing prevalence of myopia, astigmatism, and other refractive errors in the adult population with growing awareness regarding the benefits of these lenses, such as increased comfort, safety, and others, is resulting in higher adoption of these lenses among the adult population.

Moreover, the increasing approvals and launches of products for refractive errors in adults is also one of the contributing factors to the rising adoption of this lens among adults.

• In May 2021, the Cooper Companies Inc. received EU approval for its Procornea DreamLite overnight ortho-K lens for slowing the myopia progression in children and young adults.

All these factors mentioned above and a rising number of emerging players in the market are expected to spur the market during the forecast period.

By Application Analysis

To know how our report can help streamline your business, Speak to Analyst

Myopia Segment to Lead Attributable to Growing Prevalence of Myopia Among the Population 

The rising prevalence of myopia among children and the geriatric population globally and the patient's preference for non-invasive procedures over refractive surgeries are some of the major factors contributing to the segment's growth.

Additionally, the increasing efforts of international organizations and market players to increase awareness regarding myopia among the population are favoring segmental growth during the forecast period.

• In January 2022, Euclid Systems Corporation partnered with Global Specialty Lens Symposium to create awareness regarding myopia and educate eye care providers (ECPs) on advanced orthokeratology and proactive myopia management.

On the other hand, the astigmatism segment is expected to register a significant CAGR during the forecast period owing to several factors such as the growing prevalence of the condition among the population, increasing applications of this lens in the treatment of astigmatism, and others. Also, the growing adoption of these lenses among people with astigmatism is expected to drive segmental growth.

• For instance, in February 2022, according to Nvision Eye Centers, one in every three people suffered from astigmatism in the U.S.

The growing research and development activities to study the efficiency of these devices in the management of hyperopia, presbyopia, and others, along with the growing prevalence of these conditions globally, is anticipated to augment the segment's growth during the forecast period.

By End-user Analysis

Optometrists Segment to Dominate Backed by Rising Number of Prescriptions for Ortho-K Lens 

Based on end-user, the market is segmented into optometrist offices, hospitals & ophthalmology clinics, and others. The growing technological advancements in the diagnosis and treatment of refractive errors are resulting in higher adoption of these lenses among optometrists. This factor is one of the important factors stimulating the growth of the optometrist offices segment.

Also, the rising number of partnerships among market players and optometrists contributes to the segment's growth.

• For instance, in July 2022, Euclid Systems Corporation announced the interactive, web-based customer portal to practice efficiency and optimize Euclid orthokeratology fits which will help optometrists diagnose refractive errors such as myopia, hyperopia, and others. 

On the other side, the increasing number of hospitals & ophthalmology clinics rendering lens fitting services and other refractive error correction treatments is a primary factor favorable for the segment's growth during the forecast period.

REGIONAL INSIGHTS

To get more information on the regional analysis of this market, Request a Free sample

The Asia Pacific market was valued at USD 357.0 million in 2021 and dominated the global orthokeratology lens market share and is projected to register the highest CAGR during the forecast period. The increasing use of these lenses in China, Japan, and other countries owing to rising awareness of these lenses is a primary factor attributable to the segment's growth.

Moreover, growing initiatives by the government to increase awareness regarding the benefits of this lens in the treatment of refractive errors are also contributing to the market's growth.

• For instance, in June 2018, the Guide to Myopia Prevention and Control released by the National Health Commission of China listed the OK Lens as a corrective measure for myopia prevention and control.

In North America, the market is expected to grow expansively during the forecast period, owing to the rising number of mergers and acquisitions among market players to expand the product portfolio and geographical presence.

• For instance, in August 2020, the Cooper Companies Inc. acquired CE GP Specialists, one of the leading orthokeratology contact lens manufacturers and distributors, aiming to expand its product portfolio to cater to myopic population demand.

On the other hand, the increasing number of these lens prescriptions by healthcare providers in European countries is one of the major contributing factors fueling segmental growth.

• According to a 2020 article published by Elsevier, there were around 6-6.5% of orthokeratology lens prescriptions in the Netherlands in 2018. The high proportion of these lens fittings in the country was due to rising awareness regarding the treatment, an increasing number of laboratories customizing the lens design, and other factors.

Thus, all these factors mentioned above, along with the rising prevalence of myopia, astigmatism, and increasing adoption of orthokeratology, are responsible for the market's growth in emerging markets such as Latin America and the Middle East & Africa.

KEY INDUSTRY PLAYERS

The Cooper Companies Inc. Leads the Market with a Strong Focus on Increasing its Product Portfolio 

The global market is consolidated with a few major players, including the Cooper Companies Inc., Menicon Co. Ltd., Bausch Health Companies Inc., and Euclid Systems Corporation, among others holding the market's maximum share.

The market players' focus on catering to the rising demand for these lens treatments is increasing owing to the growing prevalence of refractive errors globally. Additionally, the implementation of strategies by the key players to expand their product portfolio and geographical presence is another factor contributing to the market's growth.

The Cooper Companies Inc. remained the market leader in terms of market share in 2021, owing to a strong product portfolio and robust efforts to expand the geographical presence with strategic mergers and acquisitions.

• In June 2022, the Cooper Companies Inc. acquired EnsEyes, one of the leading suppliers of OK Lens and scleral lens in Europe’s Nordic region, aiming to expand the specialty contact lens growth.

Similarly, the rising efforts of the market players, such as Menicon Co., Ltd., Euclid Systems Corporation, Bausch Health Companies Inc., and others, to expand their product portfolio by introducing innovative products to cater to the growing demand for these lenses among the patient population is expected to fuel the market share of these players in the future.

• In April 2022, Johnson & Johnson Vision Care, Inc. launched the ACUVUE ABILITI brand to address the growing prevalence and penetration of orthokeratology of myopia in Hong Kong.

Thus, the growing demand for these lenses among the population globally, along with increasing technological advancements and innovation in products, is anticipated to increase the market share of the emerging players.

LIST OF KEY COMPANIES PROFILED IN ORTHOKERATOLOGY LENS MARKET:

• The Cooper Companies Inc. (U.S.) 


• Menicon Co., Ltd. (Japan)


• Euclid Systems Corporation (U.S.)


• Bausch & Lomb Incorporated (Canada)


• Johnson & Johnson Services, Inc. (U.S.)


• Brighten Optix.Co (China)


• TruForm Optics Inc. (U.S.)


• Art Optical Contact Lens, Inc. (U.S.)

KEY INDUSTRY DEVELOPMENTS

• September 2022 - Johnson & Johnson Services Inc. received the U.S. FDA approval for ACUVUE Abiliti Overnight Therapeutic Lenses for an expanded range of upto 6.00 diopters, which was previously upto 4.00 diopters.


• April 2022 – Euclid Systems Corporation acquired Visionary Optics to enhance its product portfolio in its specialty contact lens.


• November 2021 – Johnson & Johnson Services Inc. received the U.S. FDA approval for ACUVUE Abiliti Overnight Therapeutic Lenses for myopia management.


• April 2021 - Menicon Co., Ltd. collaborated with Johnson & Johnson Vision to bring forward therapeutic lens related products and services to combat myopia in children.


• August 2020 – The Cooper Companies Inc. acquired C&E GP Specialists Inc., one of the leading contact lens manufacturers and distributors, to expand CooperVision’s specialty eye care business and address the increasing severity and prevalence of myopia.

REPORT COVERAGE

An Infographic Representation of Orthokeratology Lens Market

View Full Infographic

To get information on various segments, share your queries with us

The research report covers a detailed market analysis and overview. It focuses on key aspects such as competitive landscape, product type, and indication. Besides this, it offers insights into the market trends, market dynamics, COVID-19 impact on the market, and other key insights. In addition to the factors mentioned above, the report encompasses several factors that have contributed to the market's growth in recent years.

Report Scope & Segmentation